manipulating the mRNA process has been a point of study for decades.

That process started with two researchers in the 90’s and then companies started to see the potential in mRNA.

“Companies like Moderna learned this basic finding about 10-years ago. They recognized the importance of the findings in production of vaccines,” said Moon.

Decades of successful and unsuccessful research was furthered by the National Institutes of Health and their 10 partner labs at various universities. The process used in the COVID-19 vaccines was also used by the labs to attempt to find solutions to flu and HIV.